Delve into a groundbreaking panel discussion featuring leading experts in cancer research and genomics as they explore the potential of The Cancer Genome Atlas to revolutionize our approach to fighting cancer. Learn about the history of cancer treatment, the misconceptions of the past, and how genomic understanding is shifting the balance in the war against this deadly disease. Discover the importance of collaboration in scientific research, the implications for global health, and the potential for classifying cancers by their mutations. Explore the future of drug development and marketing in light of genomic advancements, and gain insight into what motivates these brilliant minds to pursue their work. This thought-provoking conversation offers a comprehensive look at the cutting-edge of cancer research and its potential to transform patient outcomes.
Overview
Syllabus
A closer look at cancer.
Richard Besser's introduction.
Participant Introductions.
What is the cancer genome project?
Where does the understanding of genomics put us today?
What were the misconception of the past?
Is the more is better idea really better?
Imputing some numbers into the cancer equation.
Will there be more payoff with the human genome project or the cancer genome project?
Mary-Claire King's discoveries and breakthroughs.
Does collaboration always produce better results?
Should there be a shift in global health?
Can we classify cancers by their mutations.
When you understand the genetics then what?
Being able to predict addictions.
The death of drug companies.
As we understand genomics better how do you market these drugs?
What drives you to do this work?
Taught by
World Science Festival
